Un programa de licencias para la venta de tabaco entra en vigor para responsabilizar a los minoristas en Clovis de cumplir con las leyes estatales y locales, enfrentando fuertes sanciones, incluyendo suspensión y revocación de licencias si no lo hacen.
Today, the Food and Drug Administration (FDA) dealt a blow to public health by authorizing the sale of four menthol e-cigarettes manufactured by NJOY LLC.
El Gobernador DeSantis promulgó la propuesta de ley HB885, la cual amplía el acceso de los pacientes a las pruebas de biomarcadores, una herramienta clave utilizada por médicos para identificar el tratamiento más eficaz contra el cáncer y otras enfermedades.
JUNEAU, Alaska -- The passage of two bills late in the 2024 legislative session marks a significant step forward in easing the cancer burden in Alaska.
Earlier today, the New Jersey State Assembly Financial Institutions & Insurance Committee voted to move the Louisa Carmen Medical Debt Relief Act forward. A3861, sponsored by Assemblywoman Verlina Reynolds-Jackson, Assemblyman Wayne DeAngelo, Assemblyman Anthony Verrelli and Assemblyman Herb Conaway, will now head to the Assembly floor for further consideration.
Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, applaud the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al.
Today, the House Insurance Committee passed legislation that would increase access to biomarker testing.
Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration.
The Consumer Financial Protection Bureau (CFPB) released a proposed rule today to lessen the impact of medical debt on an individual’s credit.
This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.